Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk-A Single Center Experience.

Belatacept cardiovascular high risk kidney transplantation outcome

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
03 Aug 2019
Historique:
received: 02 07 2019
revised: 31 07 2019
accepted: 01 08 2019
entrez: 7 8 2019
pubmed: 7 8 2019
medline: 7 8 2019
Statut: epublish

Résumé

Belatacept is an attractive option for immunosuppression after renal transplantation. Renal allograft function is superior when compared to calcineurin inhibitor (CNI) based therapy in "de novo" treated patients and it has also been proposed that individuals at high cardiovascular (CV) risk may benefit most. In this retrospective cohort study, we assessed the efficacy and safety of treating patients at high cardiovascular risk with Belatacept (

Identifiants

pubmed: 31382583
pii: jcm8081164
doi: 10.3390/jcm8081164
pmc: PMC6723198
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2007 Dec 20;357(25):2562-75
pubmed: 18094377
Transplantation. 2009 Mar 27;87(6):926-33
pubmed: 19300198
Transplantation. 2009 Apr 27;87(8 Suppl):S23-6
pubmed: 19384183
Am J Transplant. 2010 Mar;10(3):535-46
pubmed: 20415897
Am J Transplant. 2010 Mar;10(3):547-57
pubmed: 20415898
Am J Transplant. 2011 Mar;11(3):450-62
pubmed: 20973913
Clin J Am Soc Nephrol. 2011 Feb;6(2):430-9
pubmed: 21051752
Am J Transplant. 2012 Jan;12(1):210-7
pubmed: 21992533
Transpl Int. 2012 Oct;25(10):1059-64
pubmed: 22816557
Am J Transplant. 2013 Nov;13(11):2875-83
pubmed: 24047110
Transplant Rev (Orlando). 2014 Apr;28(2):37-46
pubmed: 24507957
Clin Transplant. 2014 Sep;28(9):1004-9
pubmed: 24974984
Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010699
pubmed: 25416857
Nefrologia. 2015;35(1):58-65
pubmed: 25611834
Am J Transplant. 2015 Oct;15(10):2726-31
pubmed: 25988397
Am J Transplant. 2016 Jul;16(7):2181-6
pubmed: 26718625
N Engl J Med. 2016 Jan 28;374(4):333-43
pubmed: 26816011
Am J Transplant. 2016 Nov;16(11):3192-3201
pubmed: 27130868
Am J Transplant. 2017 Jan;17(1):180-190
pubmed: 27232116
Am J Kidney Dis. 2017 May;69(5):587-594
pubmed: 27889299
Am J Transplant. 2017 Nov;17(11):2937-2944
pubmed: 28707779
Clin Kidney J. 2018 Jun;11(3):413-421
pubmed: 29988241

Auteurs

Hannes Neuwirt (H)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria. Hannes.Neuwirt@i-med.ac.at.

Irmgard Leitner-Lechner (I)

Department of Pharmacology, Section for Molecular and Cellular Pharmacology, Medical University of Innsbruck, Peter-Mayr-Strasse 1a, Innsbruck 6020, Austria.

Julia Kerschbaum (J)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Michael Ertl (M)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Florian Pöggsteiner (F)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Nicolas Pölt (N)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Julius Mätzler (J)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Hannelore Sprenger-Mähr (H)

Landeskrankenhaus Feldkirch, Department of Internal Medicine III-Nephrology, Carinagasse 47, Feldkirch 6800, Austria.

Michael Rudnicki (M)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Peter Schratzberger (P)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Iris E Eder (IE)

Department of Urology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Gert Mayer (G)

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria.

Classifications MeSH